Gyre Therapeutics Inc
(GYRE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 14,473 | 9,935 | -85,480 | 15,497 | 7,987 |
| Depreciation Amortization | 643 | 415 | 1,114 | 806 | 604 |
| Income taxes - deferred | -410 | -313 | -1,160 | -757 | -558 |
| Accounts receivable | -3,361 | -31 | 285 | 2,651 | 3,461 |
| Accounts payable and accrued liabilities | -83 | -23 | 192 | -105 | 39 |
| Other Working Capital | -10,142 | -2,757 | 7,458 | 5,991 | 6,611 |
| Other Operating Activity | -3,729 | -4,342 | 103,483 | -1,551 | -3,194 |
| Operating Cash Flow | $-2,609 | $2,884 | $25,892 | $22,532 | $14,950 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | -1,000 | -1,000 | N/A |
| PPE Investments | -1,419 | -181 | -7,853 | -5,696 | -4,085 |
| Net Acquisitions | N/A | N/A | -124 | N/A | N/A |
| Purchase Of Investment | -14,074 | -7,039 | -15,735 | -14,335 | -11,548 |
| Purchase Sale Intangibles | N/A | N/A | -69 | -68 | -66 |
| Other Investing Activity | 0 | 0 | 4,952 | -68 | -66 |
| Investing Cash Flow | $-15,493 | $-7,220 | $-19,760 | $-21,099 | $-15,699 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 933 | 658 | N/A | N/A | N/A |
| Other Financing Activity | -119 | 0 | 2,500 | 0 | 0 |
| Financing Cash Flow | $814 | $658 | $2,500 | $N/A | $N/A |
| Exchange Rate Effect | -124 | -46 | -298 | -529 | -700 |
| Beginning Cash Position | 33,509 | 33,509 | 25,175 | 25,175 | 25,175 |
| End Cash Position | 16,097 | 29,785 | 33,509 | 26,079 | 23,726 |
| Net Cash Flow | $-17,412 | $-3,724 | $8,334 | $904 | $-1,449 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,609 | 2,884 | 25,892 | 22,532 | 14,950 |
| Capital Expenditure | -1,687 | -231 | -8,517 | -6,193 | -4,219 |
| Free Cash Flow | -4,296 | 2,653 | 17,375 | 16,339 | 10,731 |